All Stories

  1. Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected Percutaneous Coronary Intervention: Report from the Roma-Verona Registry
  2. Percutaneous transcatheter aortic valve replacement induces femoral artery shrinkage: angiographic evidence and predictors for a new side effect
  3. Successful transradial removal of an inflated coronary stent dislodged from the right coronary ostium
  4. Seguimiento de 3 años de pacientes con lesiones de bifurcación tratados con stents liberadores de sirolimus o everolimus: estudio de colaboración de SEAside y CORpal
  5. Three-year Follow-up of Patients With Bifurcation Lesions Treated With Sirolimus- or Everolimus-eluting Stents: SEAside and CORpal Cooperative Study
  6. Intramural hematoma occurring after coronary stenting
  7. Percutaneous Closure of a Small Posterior Mitral Paravalvular Leak in a Patient With Coexistent Monoleaflet Mechanical Aortic Valve
  8. Optical Frequency-Domain Imaging to Guide Implantation of a Paclitaxel-Eluting Stent in the Femoral Artery
  9. Excimer laser for a highly stenotic saphenous vein graft: evidence of debulking by optical coherence tomography
  10. Post-procedural renal microvascular perfusion measured using the Quantitative Blush Evaluator (QuBE) predicts improvement in renal function in patients undergoing percutaneous renal artery stenting
  11. Meta‐analysis of bioabsorbable versus durable polymer drug‐eluting stents in 20,005 patients with coronary artery disease: An update
  12. Morphological–biohumoral correlations in acute coronary syndromes: Pathogenetic implications
  13. Paclitaxel-Eluting Balloon vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: The DEBATE-ISR Study
  14. Pancoronary plaque vulnerability in patients with acute coronary syndrome and ruptured culprit plaque: A 3-vessel optical coherence tomography study
  15. Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting
  16. Drug-Eluting Balloon in Peripheral Intervention for the Superficial Femoral Artery
  17. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: A randomized trial
  18. Case-Control Registry of Excimer Laser Coronary Angioplasty Versus Distal Protection Devices in Patients With Acute Coronary Syndromes due to Saphenous Vein Graft Disease
  19. Correlation Between Degree of Neointimal Hyperplasia and Incidence and Characteristics of Neoatherosclerosis as Assessed by Optical Coherence Tomography
  20. Radial artery complications occurring after transradial coronary procedures using long hydrophilic-coated introducer sheath: a frequency domain-optical coherence tomography study
  21. Intracoronary bivalirudin
  22. TCT-843 Drug eluting balloon vs drug eluting stent in PCI: insights from a meta-analysis of 1462 patients.
  23. Comparison of pre-hospital 600mg or 900mg vs. peri-interventional 300mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load&Go randomized trial
  24. Frequency-domain optical coherence tomography assessment of kissing-balloon effects in bifurcated coronary artery lesions undergoing provisional stenting
  25. Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome
  26. Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: Insights from a meta-analysis of 1462 patients
  27. No-Reflow Reversibility: A Study Based on Serial Assessment of Multiple Biomarkers
  28. Stress cardiomyopathy (tako-tsubo) triggered by nervous system diseases: A systematic review of the reported cases
  29. Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures
  30. Endothelial Progenitor Cells, Microvascular Obstruction, and Left Ventricular Remodeling in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
  31. Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: A prospective study
  32. EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions
  33. Editorial (Hot Topic: No Reflow: What’s in a Name?)
  34. Mechanisms, Prevention and Treatment of Distal Embolization
  35. Bilateral intralobar pulmonary sequestrations receiving separate arterial supply from the right and circumflex coronary arteries: A case report
  36. Open-Label, Randomized, Placebo-Controlled Evaluation of Intracoronary Adenosine or Nitroprusside After Thrombus Aspiration During Primary Percutaneous Coronary Intervention for the Prevention of Microvascular Obstruction in Acute Myocardial Infarction
  37. Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: A procedural performance comparison with sirolimus- and everolimus-eluting stents
  38. CORRELATION BETWEEN DEGREE OF NEOINTIMAL HYPERPLASIA AND INCIDENCE AND CHARACTERISTICS OF NEOATHEROSCLEROSIS AFTER STENT IMPLANTATION: AN OPTICAL COHERENCE TOMOGRAPHY STUDY
  39. Immediate evidence of the benefit of distal protection in vein graft intervention
  40. The HEART study
  41. Drug-Eluting Balloon Angioplasty for Carotid In-Stent Restenosis
  42. One‐year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug‐eluting stent technology
  43. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l’Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study
  44. Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: the BINARIO (BIcarbonato e N-Acetil-cisteina nell’infaRto mIocardico acutO) study
  45. TCT-343 Paclitaxel Drug Eluting Balloon Versus Standard Angioplasty To Reduce Restenosis In Diabetic Patients With In Stent Restenosis Of The Superficial Femoral And Proximal Popliteal Artery
  46. Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions
  47. TCT-680 Long Term Outcome of Patients With Bifurcated Lesions Randomized to Sirolimus or Everolimus Eluting Stent: The Sea-Corp BC Study
  48. Late (3 Years) Follow-Up of Successful Versus Unsuccessful Revascularization in Chronic Total Coronary Occlusions Treated by Drug Eluting Stent
  49. Superficial calcified nodules and post-stenting micro-dissections imaged through 3-dimensional optical coherence tomography
  50. Comparison of Two- and Three-Dimensional Quantitative Coronary Angiography to Intravascular Ultrasound in the Assessment of Intermediate Left Main Stenosis
  51. INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial
  52. Impact of radial‐to‐aorta vascular anatomical variants on risk of failure in trans‐radial coronary procedures
  53. Cilostazol and Primary-PCI: Mirage or Good Alternative?
  54. Coronary artery perforation imaged through 3-dimensional optical coherence tomography
  55. Prevention and Treatment of Coronary Distal Embolization in the Setting of Acute Myocardial Infarction: Pharmacologic Approach
  56. Angiographic versus functional assessment of coronary artery disease: A ?proof of concept? case report
  57. Maximal Hyperemia in the Assessment of Fractional Flow Reserve
  58. Early beneficial effects of drug‐eluting stents in vein grafts wane during long term follow‐up
  59. Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures
  60. Integrated Imaging
  61. Other Clinical Indications: Sports Practice in Individuals with Patent Foramen Ovale and in Patients Undergoing Non-Coronary Interventional Procedures
  62. Differences in Microparticle Release in Patients With Acute Coronary Syndrome and Stable Angina
  63. Prospective evaluation of myocardial ischemia related to post‐procedural side‐branch stenosis in bifurcated lesions treated by provisional approach with drug‐eluting stents
  64. Telmisartan for the Prevention of Acute Coronary Syndrome in ACE-Inhibitor-Intolerant Patients
  65. Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts: incidence, predictors and effect of the type of protection device
  66. Left anterior descending artery percutaneous coronary intervention from the right radial access via the left internal mammary artery: a case report
  67. Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling
  68. Predictors of myocardial microvascular obstruction in patients treated by primary percutaneous coronary intervention and a short ischemic time
  69. Quantitative Blush Evaluator accurately quantifies microvascular dysfunction in patients with ST-elevation myocardial infarction: Comparison with cardiovascular magnetic resonance
  70. A meta-analysis of first-generation drug-eluting vs bare-metal stents for coronary chronic total occlusion: Effect of length of follow-up on clinical outcome
  71. CT angiography with cardiac MRI: non-invasive functional and anatomical assessment for the etiology in newly diagnosed heart failure
  72. Microparticles in Health and Disease: Small Mediators, Large Role?
  73. Evaluation of the “Learning Curve” for Left and Right Radial Approach During Percutaneous Coronary Procedures
  74. Safety and efficacy of G-CSF in patients with ischemic heart failure: The CORNER (Cell Option for Recovery in the Non-Eligible patients for Revascularization) study
  75. Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study
  76. Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events
  77. USE OF DRUG-ELUTING STENTS IN VEIN GRAFT: RESULTS OF A MULTICENTRIC REGISTRY
  78. QUANTITATIVE BLUSH EVALUATOR (QUBE) COMPARISON WITH EARLY CARDIOVASCULAR MAGNETIC RESONANCE IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION
  79. Microparticles in Health and Disease: Small Mediators, Large Role?
  80. Eosinophil cationic protein and clinical outcome after bare metal stent implantation
  81. Prospective Randomized Comparison of Sirolimus- or Everolimus-Eluting Stent to Treat Bifurcated Lesions by Provisional Approach
  82. Comparative assessment of mammalian target of rapamycin inhibitor‐eluting stents in the treatment of coronary artery bifurcation lesions: The CASTOR‐Bifurcation registry
  83. Quantitative blush evaluator (QuBE) accurately quantifies microvascular dysfunction in patients with ST-Elevation Myocardial Infarction; comparison with Cardiovascular Magnetic Resonance
  84. Peripheral levels of circulating progenitor cells correlate with area at risk and microvascular obstruction at cardiac magnetic resonance imaging in patients with ST-elevation myocardial infarction
  85. La TC coronarica
  86. Glucose-6-Phosphate Dehydrogenase (G6PDH) Deficiency in a Patient with ST-Segment Elevation Acute Myocardial Infarction Successfully Treated by Simple Thrombectomy
  87. Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?
  88. Angiographic assessment of microvascular perfusion—Myocardial blush in clinical practice
  89. Intravascular ultrasound-guided sealing of left anterior descending aneurysm with microcavities causing distal embolization
  90. Yin and Yang in Interventional Cardiology
  91. Renal artery stenting in patients with chronic ischemic heart disease
  92. Intracoronary imaging in chronic total occlusions
  93. Chronic total occlusion special issue
  94. Angiographic Predictors of Recurrent Stent Thrombosis (from the Outcome of PCI for Stent-ThrombosIs MultIcentre STudy [OPTIMIST])
  95. A case of variant angina in a patient under chronic treatment with sorafenib
  96. MICROPARTICLES SHEDDING AFTER PERCUTANEOUS CORONARY INTERVENTION IN UNSTABLE ANGINA IS MODULATED BY MYOCARDIAL NECROSIS AND SYSTEMIC INFLAMMATION
  97. PLATELET-DERIVED MICROPARTICLES AND C-REACTIVE PROTEIN IN INTRACORONARY AND PERIPHERAL BLOOD OF ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS.
  98. Effect of Chronic Aspirin Therapy on Angiographic Thrombotic Burden in Patients Admitted for a First ST-Elevation Myocardial Infarction
  99. INCREASED LEVELS OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN INTRACORONARY BLOOD OF ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS CORRELATE WITH MICROVASCULAR DAMAGE.
  100. Coronary bifurcation lesions: To stent one branch or both? A meta-analysis of patients treated with drug eluting stents
  101. Platelet P2Y12 receptor inhibition by thienopyridines: status and future
  102. Elevated admission cardiac troponin T is associated with microvascular dysfunction in acute myocardial infarction treated with emergency angioplasty
  103. The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention
  104. Comparison of the Effects of Ramipril Versus Telmisartan on High-Sensitivity C-Reactive Protein and Endothelial Progenitor Cells After Acute Coronary Syndrome
  105. Evaluación de una estrategia de implantación de stent único o doble para tratar lesiones bifurcadas basada en la clasificación de Medina
  106. Evaluation of a Strategy for Treating Bifurcated Lesions by Single or Double Stenting Based on the Medina Classification
  107. Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the ‘OPTIMIZE-IT’ pilot randomized study
  108. Outcome of patients treated by a novel thin‐strut cobalt‐chromium stent in the drug‐eluting stent era: Results of the SKICE (Skylor in real world practice) registry
  109. Nonconventional use of coronary guidewires for ECG recording and emergency pacing
  110. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial
  111. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study
  112. Pharmacogenetic Modulation of Platelet Inhibition
  113. Long term outcome of elective day case percutaneous coronary intervention in patients with stable angina
  114. Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate
  115. Plaque Burden, Intravascular Ultrasound, and Distal Embolization Phenomenon
  116. Dynamic thrombosis associated with bare-metal stent malapposition in a patient with hyperhomocysteinemia
  117. Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina
  118. Ethanol Abolishes Ischemic Preconditioning in Humans
  119. Adjunctive devices in primary or rescue PCI: A meta-analysis of randomized trials
  120. Coronary arteriovenous fistula following X-sizer thrombectomy
  121. Instability mechanisms in unstable angina according to baseline serum levels of C-reactive protein: The role of thrombosis, fibrinolysis and atherosclerotic burden
  122. Usefulness of Granulocyte Colony-Stimulating Factor in Patients With a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling (The Rigenera Study)
  123. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation
  124. Adjusted Indirect Meta-Analysis of Aspirin Plus Warfarin at International Normalized Ratios 2 to 3 Versus Aspirin Plus Clopidogrel After Acute Coronary Syndromes
  125. Relation of Myocardial Blush Grade to Microvascular Perfusion and Myocardial Infarct Size After Primary or Rescue Percutaneous Coronary Intervention
  126. Lost and found: An unusual late complication of the Angio-Seal closure device
  127. Prediction of Distal Embolization During Percutaneous Coronary Intervention in Saphenous Vein Grafts
  128. Guide wire fracture with retained filament in the LAD and aorta
  129. Pharmacological Management of No Reflow During Percutaneous Coronary Intervention
  130. A case of multivessel coronary artery spasm resulting in wandering ST segment elevation
  131. Percutaneous treatment of simultaneous aortic dissection and pericardial tamponade during coronary intervention
  132. Safety of Magnetic Resonance Imaging One to Three Days After Bare Metal and Drug-Eluting Stent Implantation
  133. Left main and saphenous vein graft spasm: an unusual association
  134. Interplay of platelet polymorphisms, risk factors, and Von Willebrand factor, and flow-mediated conditions in determining collagen–adenosine diphosphate PFA-100 results in patients with coronary artery disease
  135. Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis
  136. Spontaneous Echocardiographic Contrast in the Ascending Aorta Mimicking the Appearance of Aortic Dissection in a Patient with a Left Ventricular Assist Device